Login / Signup
Elham Madreseh
ORCID
Publication Activity (10 Years)
Years Active: 2020-2024
Publications (10 Years): 2
Top Topics
Public Health
Systemic Sclerosis
Transforming Growth Factor
Top Venues
Archives of Iranian medicine
Inflammopharmacology
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Mehrnoosh Pashaei
,
Elham Farhadi
,
Hoda Kavosi
,
Elham Madreseh
,
Samaneh Enayati
,
Mahdi Mahmoudi
,
Ali Akbar Amirzargar
Talabostat, fibroblast activation protein inhibitor, attenuates inflammation and fibrosis in systemic sclerosis.
Inflammopharmacology
(2024)
Elham Madreseh
,
Mahmood Mahmoudi
,
Mohssen Nassiri-Toosi
,
Taban Baghfalaki
,
Hojjat Zeraati
Post Liver Transplantation Survival and Related Prognostic Factors among Adult Recipients in Tehran Liver Transplant Center; 2002-2019.
Archives of Iranian medicine
23 (5) (2020)